Florida is Next In Line To Decriminalize Psychedelics

A Florida State democratic Rep. Michael Grieco, who represents Miami Beach in the state legislature, represents the first serious push for legal access to psilocybin on the East Coast.

This bill would legalize magic mushrooms and give patients safe access to psychedelics for psychedelic assisted psychotherapy. The bill was introduced after similar initiatives in Oregon and Washington D.C. were passed in 2020. Grieco was proposing legal access as well as consumption of psilocybin mushrooms. In Florida, access will be limited to people with a diagnosis of a mental health condition. That would mean limited legal access to mushrooms for psychedelic assisted psychotherapy for military veterans with PTSD and terminally ill patients. Florida comes in third with the highest concentrations of veterans, behind California and Texas. Once the bill's language is approved it will go through an “administrative review” process but Grieco expects the bill is unlikely to pass due to serious opposition from lawmakers and public health officials in Tallahassee. The objective is to get the conversation started surrounding decriminalization of psychedelics and to give universities a path to studying the therapeutic potential of these profound and potent natural substances. An attorney who helped draft the language of the bill's states, "This bill symbolizes the seed that will soon blossom into the widespread acceptance of psychedelics, which will ultimately lead to the healing and compassion that our society desperately needs.” 


SykoActive

Graham Krutch, also known as 'Gram Kracker,' is the founder and CEO of SykoActive Non-Profit Association, boasting over two decades of experience in the industry of medicinal plants and psychedelic substances. His expertise extends from cultivation to patient consultation, primarily focusing on cannabis and psilocybin, alongside notable advancements in the hemp and CBD sector.

Under Graham's guidance, SykoActive investigates and advocates for the therapeutic uses of psychedelic plant medicines. He is committed to informing the public about secure alternative treatments and tackling the worldwide mental health dilemma.

Beyond his involvement in the psychedelic realm, Graham possesses a varied skill set in event marketing and product management. His efforts have been instrumental in the prosperity of leading convenience stores, and he shines in team leadership, strategic planning, and project management. As a fervent proponent of Applied AI Science and proficient in AI research and technological tools, he adeptly merges a customer-centric approach with an acute awareness of time constraints.

https://www.sykoactive.com
Previous
Previous

The Psychedelics Science Funders Collaborative Guides Investors In The Right Direction

Next
Next

Pharmadrug Files for FDA Orphan Drug Destination for DMT Treatments